APMD (Apnimed) Net Margin %: 1,042.51% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

APMD Apnimed Inc APMD
8 GF Score
Price $28.07
View Full Analysis

What is Apnimed Net Margin %?

Apnimed APMD +3.50% 8 Net Margin % is 1,042.51% as of Jun. 2026. GuruFocus rates APMD with a GF Score™ of 8/100. Among 949 Biotechnology companies, Apnimed ranks better than 68.81% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Apnimed's Net Income for the three months ended in Jun. 2026 was $125.94 Mil. Apnimed's Revenue for the three months ended in Jun. 2026 was $12.08 Mil. Therefore, Apnimed's net margin for the quarter that ended in Jun. 2026 was 1,042.51%.

The historical rank and industry rank for Apnimed's Net Margin % or its related term are showing as below:

APMD' s Net Margin % Range Over the Past 10 Years
Min: -1389.23   Med: -695.83   Max: -2.42
Current: -2.42

APMD's Net Margin % is ranked better than
68.81% of 949 companies
in the Biotechnology industry
Industry Median: -77.58 vs APMD: -2.42

Apnimed  (NAS:APMD) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Apnimed Net Margin % Related Terms

Apnimed Net Margin % Historical Data

* Premium members only.

The historical data trend for Apnimed's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apnimed Net Margin % Chart

Apnimed Annual Data
Trend Dec24 Dec25
Net Margin %
-1,389.23 -333.25

Apnimed Quarterly Data
Mar25 Jun25 Mar26 Jun26
Net Margin % -914.92 -406.04 79.84 1,042.51

APMD vs SANA, CRVS, ODTX: Net Margin % Comparison

For the Biotechnology subindustry, Apnimed's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apnimed Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Apnimed's Net Margin % distribution charts can be found below:

* The bar in red indicates where Apnimed's Net Margin % falls into.


APMD
8GF Score
Apnimed Inc APMD
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apnimed Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Apnimed's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-128.191/38.467
=-333.25 %

Apnimed's Net Margin for the quarter that ended in Jun. 2026 is calculated as

Net Margin=Net Income (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=125.935/12.08
=1,042.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 1,042.51% mean?
Apnimed (APMD) has a Net Margin % of 1,042.51% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Apnimed and its competitors. According to the industry distribution chart, Apnimed ranks #296 out of 949 companies in the Biotechnology industry, placing it in the top 31.2%.
Is Apnimed's Net Margin % too high?
Apnimed's current Net Margin % is 1,042.51%. Based on the distribution chart, Apnimed ranks #296 out of 949 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Apnimed has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Apnimed's Net Margin % compare to SANA and CRVS?
According to the Biotechnology industry distribution chart, Apnimed ranks #296 out of 949 companies for Net Margin %. This puts Apnimed in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Apnimed and its competitors. Apnimed's current Net Margin % is 1,042.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apnimed stock overvalued right now?
Apnimed (APMD) has a current Net Margin % of 1,042.51%. The current Net Margin % is 1,042.51%. Apnimed's overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Apnimed (APMD), the current Net Margin % is 1,042.51% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apnimed Business Description

Address 39 John F. Kennedy Street, 4th Floor, Cambridge, MA, USA, 02138
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
8GF Score

Get the complete analysis for APMD

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.07
Price